Aquestive Therapeutics (AQST) nnounces Late-Breaking Findings of its Investigational DBF Formulation in Adults with Epilepsy
Tweet Send to a Friend
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company, today announced findings from two clinical studies, including the Adult ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
